153 related articles for article (PubMed ID: 24090654)
1. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
Prochnow N; Gold R; Haghikia A
J Neuroimmunol; 2013 Nov; 264(1-2):48-53. PubMed ID: 24090654
[TBL] [Abstract][Full Text] [Related]
2. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
3. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
[TBL] [Abstract][Full Text] [Related]
4. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
5. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
7. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Potter LE; Paylor JW; Suh JS; Tenorio G; Caliaperumal J; Colbourne F; Baker G; Winship I; Kerr BJ
J Neuroinflammation; 2016 Jun; 13(1):142. PubMed ID: 27282914
[TBL] [Abstract][Full Text] [Related]
8. Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise.
Bernardes D; Oliveira-Lima OC; Silva TV; Faraco CC; Leite HR; Juliano MA; Santos DM; Bethea JR; Brambilla R; Orian JM; Arantes RM; Carvalho-Tavares J
J Neuroimmunol; 2013 Nov; 264(1-2):24-34. PubMed ID: 24054000
[TBL] [Abstract][Full Text] [Related]
9. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
10. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
[TBL] [Abstract][Full Text] [Related]
11. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
J Neuroimmunol; 2014 Nov; 276(1-2):89-97. PubMed ID: 25200475
[TBL] [Abstract][Full Text] [Related]
13. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis.
Rossi S; Furlan R; De Chiara V; Musella A; Lo Giudice T; Mataluni G; Cavasinni F; Cantarella C; Bernardi G; Muzio L; Martorana A; Martino G; Centonze D
Neurobiol Dis; 2009 Oct; 36(1):51-9. PubMed ID: 19591937
[TBL] [Abstract][Full Text] [Related]
14. Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Huang Q; Ma X; Zhu DL; Chen L; Jiang Y; Zhou L; Cen L; Pi R; Chen X
J Neuroimmunol; 2015 Jul; 284():67-73. PubMed ID: 26025060
[TBL] [Abstract][Full Text] [Related]
15. Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Frezel N; Sohet F; Daneman R; Basbaum AI; Braz JM
Exp Neurol; 2016 Sep; 283(Pt A):224-34. PubMed ID: 27343802
[TBL] [Abstract][Full Text] [Related]
16. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Ruffini F; Rossi S; Bergamaschi A; Brambilla E; Finardi A; Motta C; Studer V; Barbieri F; De Chiara V; Hayardeny L; Comi G; Centonze D; Martino G
Mult Scler; 2013 Jul; 19(8):1084-94. PubMed ID: 23232603
[TBL] [Abstract][Full Text] [Related]
17. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
[TBL] [Abstract][Full Text] [Related]
18. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
[TBL] [Abstract][Full Text] [Related]
19. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
[TBL] [Abstract][Full Text] [Related]
20. The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Polak PE; Lin SX; Pelligrino D; Feinstein DL
J Neuroimmunol; 2014 Nov; 276(1-2):135-41. PubMed ID: 25242632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
